title: The case for intravenous arginine stimulation in lieu of mixed-meal tolerance tests as outcome measure for intervention studies in recent-onset type 1 diabetes.
authors.affiliation: Benaroya Research Institute, Diabetes Clinical Research, Seattle, Washington 98101, USA. cjgreen@benaroyaresearch.org
authors.forename: Carla
authors.initials: C
authors.lastname: Greenbaum
authors.forename: Kristy
authors.initials: K
authors.lastname: Seidel
authors.forename: Catherine
authors.initials: C
authors.lastname: Pihoker
mesh_terms: D001120:Arginine / Q000008:administration & dosage; D002096:C-Peptide / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000097:blood*; D005951:Glucose Tolerance Test / Q000379:methods*; D006801:Humans; D007275:Injections, Intravenous; D019518:Postprandial Period; D015203:Reproducibility of Results; D016896:Treatment Outcome
chemical_list: D002096:C-Peptide; D001120:Arginine